Remove facilities facility-design-management
article thumbnail

Advanced Therapy and Advanced Manufacturing for Unmet Medical Needs

ISPE

The emergence of new therapies leads to the need for multi-modal manufacturing facilities. supply chain management, pharmaceutical quality system, and so on). This encompasses process development, facility design, equipment selection, quality system establishment, supply chain management, as well as personnel training.

article thumbnail

New partnership to advance European oligonucleotide manufacturing

European Pharmaceutical Review

A current good manufacturing practice (cGMP) oligonucleotide manufacturing facility is set to be built Berlin. This has been driven by recent advancements in nucleic acid chemistry and cell biology, which have supported improved design, optimisation and delivery mechanisms, according to Asahi Kasei Bioprocess and Axolabs.

52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Meet the 2023 Foya Supply Chain and Social Impact Categories Winner: SERUM Institute of India Pvt. Ltd.

ISPE

Marcy Sanford 13 September 2023 Facility of the Year Award (FOYA) Winners in the Supply Chain category exemplify novel application of principles, systems, and management tools aimed at improving operational speed, robustness, and response. SERUM is uniquely placed in the biotechnology industry.

article thumbnail

Discover, Delve, and Develop: Expert Workshops at the 2023 ISPE Annual Meeting & Expo

ISPE

™, Quality Risk Management (QRM), Contamination Control Strategy (CCS) and Annex 1, Facility Design and Operations, Artificial Intelligence and Machine Learning, and Professional Development. to help facilitate participants in developing a CCS using a case study and supporting documentation from an existing cGMP facility.

article thumbnail

STAT+: Biden admin proposes fixes to No Surprises Act’s dispute resolution process

STAT

The Biden administration dropped a new proposal Friday designed to fix the controversial dispute resolution process that’s part of the federal surprise billing ban. But the behind-the-scenes battles between those providers and health insurers over what that care should cost have gotten ugly.

Insurance 112
article thumbnail

The Next Horizon for Therapy Innovations

ISPE

Many of these requirements include adhering to global regulatory harmonization, improving supply chain robustness, minimizing drug shortages, reducing the complexity of managing product life cycles, and reducing the environmental impact of pharmaceutical processes. One of the sessions will delve into this aspect of industry development.

article thumbnail

What can we learn from contamination control failures?

European Pharmaceutical Review

However, she notes that useful information for assessing risks in your facility and preparing for upcoming inspections can be gleaned from other’s warning letters and regulatory inspection observation reports, such as FDA 483. The other observations related to facility design and cleanliness.